Radboud Annals of Medical Students

RAMS

  • Home
  • Sign up – Masterclasses 2023!
  • News
    • Newsletter archive
  • About
    • RAMS
    • The Board
    • The General Board
      • The General Board (2022-2023)
      • Previous General Boards
    • The Editorial Board
      • The Editorial Board (2022-2023)
      • Previous Editorial Boards
    • The Supervisory Board
    • Reviewers and Editors
    • RAMS Committees
      • Symposium Committee
      • Masterclass Committee
  • Editions
    • 2021-2022
      • Twentieth Edition – September 2021
      • Twentyfirst Edition – December 2021
      • Twenty second Edition – March 2022
    • 2020-2021
      • Sixteenth edition – September 2020
      • Seventeenth edition – December 2020
      • Eighteenth edition – March 2021
      • Nineteenth Edition – June 2021
    • 2019-2020
      • Fourteenth edition – December 2019
      • Fifteenth edition – April 2020
      • Sixteenth edition – September 2020
    • 2018-2019
      • Eleventh Edition – September 2018
      • Twelfth Edition – January 2019
      • Thirteenth edition – May 2019
    • 2017 – 2018
      • Ninth Edition – November 2017
      • Tenth Edition – February 2018
    • 2016-2017
      • Sixth Edition – November 2016
      • Seventh Edition – March 2017
      • Eighth Edition – July 2017
    • 2015-2016
      • Third Edition – November 2015
      • Fourth Edition – March 2016
      • Fifth Edition – June 2016
    • 2014-2015
      • Pilot Edition – June 2014
      • First Edition – January 2015
      • Second Edition – June 2015
  • For Authors
    • Submit your Article
    • Research internship
  • For Supervisors
  • For Reviewers
  • Contact
  • Privacy policy
  • Cookiebeleid (EU)
Je bent hier: Home / News / Lessons from the past

Lessons from the past

2 december 2021 by Rams

Bloodletting on prescription

Yfke Prins, BSc Medicine

Much to my surprise, an internist mentioned that the treatment of choice for a patient with polycythemia vera (PV) was bloodletting. I thought I had misunderstood her for a second, but then she repeated her sentence, probably after seeing my puzzled face. She was serious, and, as I discovered that day, bloodletting (also known as phlebotomy) is still applied in the clinic; although, much less frequent than, e.g. during the Middle Ages. In this brief message, we will discuss the history of phlebotomies and the current clinical applications. 

Most of you are probably familiar with bloodletting or phlebotomies. The procedure consists of retrieving around 350-500 millilitres of blood from the body [1]. The treatment has been used throughout history, dating back to 3.000 years ago [2]. Around 2.500 years ago, bloodletting rose in popularity. The commonly accepted theory of disease was Hippocrates’ theory: he believed that life consisted of the four elements, which were represented in the body by so-called humours, namely blood, phlegm, black bile, and yellow bile [2]. Disbalance between these humours could cause disease, meaning that the cure of diseases consisted of restoring the balance by removing one of the four humours, e.g. blood [2]. Since then, bloodletting had been accepted as a treatment for almost any illness. Bloodletting was even taken to extremes. For example, in 1799, George Washington died after a total of 1.7 litres of his blood was retrieved in an attempt to cure his (retrospectively diagnosed) acute epiglottis [1, 2]. However, gradually phlebotomies became discredited, eventually leading to its sporadic application today [2]. 

One of the diseases in which phlebotomies are still applied is PV, a myeloproliferative disease characterised by erythrocytosis (an increase in erythrocytes) and a high haemoglobin level [2, 3]. White blood cells and thrombocytes can also be increased, although the disease predominantly targets erythroid cells [2, 3]. As a result, the blood becomes viscous, leading to an increased risk of thrombosis [1, 3]. Treatment consists of phlebotomies and prophylactic platelet aggregation inhibitors [4]. In some cases, depending upon the risk profile, cytoreductive therapy, most often Hydrea (a form of oral chemotherapy), can be started [4]. In this case, the phlebotomy’s goal is to lower the viscosity of the blood by removing the excess of erythrocytes and haemoglobin [3]. The frequency and volume of the phlebotomies are guided by the haemoglobin and erythrocytes levels [1, 3]. 

However, PV is not the only disease in which bloodletting is used as a treatment – hereditary hemochromatosis is another example. This illness is most often caused by a mutation in the HFE gene, although in rare cases, other mutations can occur [5]. This mutation leads to an excess of iron, which, as the body cannot get rid of this efficiently, is stored in other organs [5]. Thus, hemochromatosis leads to organ damage, such as liver failure, diabetes, and heart failure [5]. Treatment consists of regular phlebotomies, of which the frequency and volume are adjusted based upon the ferritin levels [5]. If phlebotomies are applied in the early stages of the disease, the iron build-up and subsequent organ damage can be prevented [5]. 

Bear in mind that this is not an exhaustive list of indications. Porphyria cutanea tarda, sickle cell disease, and nonalcoholic fatty liver disease with hyperferritinemia, amongst others, are also indications for phlebotomies [3]. This shows us we can learn from the past. Although the idea of applying phlebotomies as a treatment for any disease is odd, it is rooted in truth, and it still does have its clinical applications today. For patients with e.g. hemochromatosis and PV, science in the Middle Ages was (accidentally) quite far ahead! 

References

  1. Assi, T. B., Baz, E. Current applications of therapeutic phlebotomy. Blood Transfus 12, 75-83 (2014). 
  2. Greenstone, G. The history of bloodletting. BCMJ 52, 12-14 (2010). 
  3. Kim, K., Oh, K. Clinical applications of therapeutic phlebotomy. J Blood Med 7, 139-144 (2016). 
  4. Boekhorst, P., Kevin, M-D., Raymakers, R., Schutgens, R. Van Wijk, R., Jie, K.-S et al. Guidelines for diagnosis and treatment of essential thrombocytosis, polycythaemia vera and primary myelofibrosis. Ned Tijdschr Hematol 8, 64-79 (2011). 
  5. Murphree, C., Nguyen, N., Raghunathan, V., Olson, S., DeLoughery, T. et al. Diagnosis and management of hereditary haemochromatosis. Vox Sanguinis 115(4), 255-262 (2020).

Categorie: News, Uncategorized

RAMS Newsletter

RAMS complies to the GDPR. By submitting your e-mail address to us you agree with our Privacy Policy.

Social Media


Sponsors & Partners

  • Brian Gardner
  • Lauren Mancke
  • Nathan Rice
  • Nick Croft
  • Rafal Tomal
  • Ron Rennick
© Copyright 2014 RADBOUD ANNALS OF MEDICAL STUDENTS · All Rights Reserved · Powered by PLatform11
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Altijd ingeschakeld
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDuurOmschrijving
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
OPSLAAN & ACCEPTEREN
Aangedreven door CookieYes Logo